XNAS · PCRX

+0.00% · +$0.0000 · Vol Not reported

Market closed · last close shown

Pacira BioSciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$23.24

Card

Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factors

Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · PCRX

Methodology

PCRX

Pacira BioSciences, Inc. Common Stock

Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET

63/100

BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

63/ 100

Veridion Score

BUY BIAS · HIGH confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET

Share on X →

Veridion Score History · 90D

Score not reportedVeridion does not publish a score-history trend for PCRX until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology

AI Analysis

Sovereign

Why is PCRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move PCRX next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

May 6
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Apr 20
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jan 25
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jan 15
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Nov 2
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Sep 26
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Aug 23
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
May 31
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Pacira BioSciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

Listed since

2011

Employees

829

Country

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$23.24

Last session

Day high

$23.24

Last session

Day low

$23.24

Last session

Previous close

$23.24

52W high

$27.62

-15.86% from high

52W low

$19.16

48% of range

Market cap

$916.8M

P/E

101.04×

EPS

$0.2300

Beta

0.02

Shares out

39.9M

Avg volume

654.3K

VWAP

$23.24

Last session

Price history computed in-house

-4.68%

-9.25%

+1.04%

-6.63%

YTD

-10.20%

SMA 50 $24.77 · below

SMA 200 $23.62 · below

52W position 48%

PCRX overview

Veridion Score

Not reported

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around PCRX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

PCRX insider activity

Pacira BioSciences, Inc. Common Stock

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not evaluated: the SEC filing index could not be read

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

No value-bearing Form 4 rows

The current Form 4 feed did not return value-bearing open-market rows for PCRX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in PCRX

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PCRX in the cached public ledger.

Federal contracts

PCRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for PCRX in this window.

Lobbying spend

PCRX lobbying filings, year to date.

Registered lobbying filings matched to Pacira BioSciences, Inc. Common Stock.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for PCRX in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for PCRX.

Options

Sovereign unlock shows live options positioning for PCRX.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Why is PCRX moving today?

What can move PCRX next.

PCRX overview

Related filings and maps

PCRX insider activity

PCRX contract awards, year to date.

PCRX lobbying filings, year to date.

Cross-references from this score page.

What can move PCRX next.

PCRX insider activity

Cross-references from this score page.